Featured Communications 2

Sat. May 25, 2024 10:10 AM - 11:10 AM Room 10 (G402)

Chair: Joseph T. Coyle (McLean Hospital and Harvard Medical School)

+Add all to schedule

[FC2-1] SARS-CoV-2-Driven Epidermal Growth Factor Receptor Signaling and the COVID19-Asscociated Psychosis/Schizophrenia

*Hiroyuki Nawa¹ (1. School of Pharmaceutical Sciences, Wakayama Medical University)

[FC2-2] Searching for the “magic pills“ for unmet medical needs in schizophrenia and other neuropsychiatric disorders: Learning from a novel DAO inhibitor.

Da-Zhong Luo¹, Yufeng Jane Tseng^2,3, *Wen-Sung Lai^1,3,4 (1. Department of Psychology, National Taiwan University, Taipei, Taiwan, 2. Department of Computer Science & Information Engineering, National Taiwan University, Taipei, Taiwan, 3. Neurobiology and Cognitive Science Center, National Taiwan University, Taipei, Taiwan, 4. Graduate Institute of Brain and Mind Sciences, National Taiwan University, Taipei, Taiwan)

[FC2-3] Multiomic profiling of rapid antidepressant mechanisms in a rat model of depression

*Laura Musazzi¹, Jessica Mingardi¹, Paulina Misztak¹, Chiara Magri², Paolo Martini², Alessandro Barbon² (1. University of Milano-Bicocca, 2. University of Brescia)

Session information

Featured Communications 2

[FC2-1] SARS-CoV-2-Driven Epidermal Growth Factor Receptor Signaling and the COVID19-Asscociated Psychosis/Schizophrenia

[FC2-2] Searching for the “magic pills“ for unmet medical needs in schizophrenia and other neuropsychiatric disorders: Learning from a novel DAO inhibitor.

[FC2-3] Multiomic profiling of rapid antidepressant mechanisms in a rat model of depression

Authentication